Back to Cardiology
Cardiologyv2011Evidence-Based

ATRIA Bleeding Risk Score

Determines bleeding risk for patients on warfarin therapy for atrial fibrillation. The score was developed and validated in the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) cohort and helps stratify patients into low, intermediate, and high risk categories for major hemorrhage.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
atria bleeding score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The ATRIA Bleeding Risk Score is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within cardiology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

ATRIA Score = Anemia (3 points) + Severe Renal Disease (3 points) + Age ≥75 (2 points) + Prior Hemorrhage (1 point) + Hypertension (1 point)

Clinical Pearls & Practice Notes

  • The ATRIA score was developed specifically for patients on warfarin therapy for atrial fibrillation.
  • Patients with a history of intracranial hemorrhage were likely excluded from the development cohort.
  • The score should be used in conjunction with clinical judgment and individual patient factors.
  • Some studies suggest HAS-BLED may have slightly better predictive accuracy than ATRIA.
  • Major hemorrhage is defined as fatal, requiring ≥2 units transfusion, or hemorrhage into critical anatomical site.

Evidence & Literature Citations

  1. Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, et al. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol. 2011 Jul 19;58(4):395-401. doi: 10.1016/j.jacc.2011.03.031.
  2. Roldán V, Marín F, Fernández H, Manzano-Fernández S, Gallego P, Valdés M, et al. Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy. Chest. 2013 Jan;143(1):179-184. doi: 10.1378/chest.12-0608.
  3. Senoo K, Proietti M, Lane DA, Lip GY. Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin. Am J Med. 2016 Jun;129(6):600-7. doi: 10.1016/j.amjmed.2015.10.001.

Score Interpretation Ranges

Low0 – 3 pts

Low bleeding risk

Intermediate4 – 4 pts

Intermediate bleeding risk

High5 – 10 pts

High bleeding risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.